The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the obstructive airway diseases and patients experience worse outcomes compared with asthma or COPD alone. Patients wit...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Expert Rev Clin Pharmacol
Main Authors: Louie, Samuel, Zeki, Amir A, Schivo, Michael, Chan, Andrew L, Yoneda, Ken Y, Avdalovic, Mark, Morrissey, Brian M, Albertson, Timothy E
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046086/
https://ncbi.nlm.nih.gov/pubmed/23473596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ecp.13.2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki